한글목차

세계의 임상시험 지원 서비스 시장 규모는 2033년까지 7.7%의 CAGR로 성장할 것으로 예측되고 있습니다.

임상시험 지원 서비스 시장은 제약 및 바이오테크놀러지 연구 상황을 형성하는 몇개의 매우 중요한 요인에 의해 최근 수년간 대폭적인 성장을 달성하고 있습니다. 그 중에서도 혁신적 및 전문적인 치료에 대한 수요의 증가가 임상시험 활동의 대폭적인 증가로 연결되고 있습니다. 제약기업이 미충족 의료 수요에 대응하는 최첨단 치료법의 개발을 위해 노력하는 가운데 종합적 임상시험 지원 서비스의 요구가 대폭 높아지고 있습니다.

또한 만성질환의 증가 및 고령화에 의해 보다 광범위하고 다양한 임상시험이 필요해지고 있습니다. 암, 심혈관질환, 신경질환 등의 질환이 현저하게 증가하고 있으며, 잠재적 치료법의 안전성과 유효성을 평가하기 위해 보다 대규모이고 복잡한 임상시험이 요구되고 있습니다. 이러한 복잡한 임상시험을 보다 효과적으로 진행하기 위해 제약회사 및 바이오테크놀러지 기업은 임상시험 지원 서비스를 제공하는 전문 업체의 지원을 받고 있습니다.

또한 규제 기준의 준수와 데이터 품질의 확보에 대한 초점이 증가하며 임상시험 영역에서 전문적인 전문 지식과 기술의 진보에 대한 수요가 높아지고 있습니다. 세계의 규제기관은 임상시험 데이터에 대한 감시를 강화하고 있으며, 기업은 최고의 품질 기준을 유지하는 것이 매우 중요해지고 있습니다. 따라서 전자 데이터 수집(EDC) 및 임상시험 관리 시스템(CTMS) 등의 첨단 기술 및 데이터 관리 솔루션의 채택이 데이터의 정확성, 안전성, 규제 준수를 보증하는데 있어서 매우 중요해지고 있습니다.

세계의 임상시험 지원 서비스 시장을 조사했으며, 시장 개요, 시장 성장에 대한 각종 영향요인 분석, 시장 규모의 추이·예측, 각종 구분·지역/주요 국가별 내역, 경쟁 환경, 주요 기업의 개요 등을 정리하여 전해드립니다.

목차

제1장 리포트 개요

제2장 주요 요약

제3장 시장 개요

• 주요 조사 결과
• 시장 역학
  • 시장 촉진요인
  • 시장 억제요인
  • 시장 기회
• COVID-19의 영향 분석
• Porter's Five Forces 분석
• PEST 분석

제4장 임상시험 지원 서비스 시장 분석 : 서비스별

• 주요 조사 결과
• 시장 매력 지수
• 시장 규모 추산·예측
• 임상시험 시설 관리
• 환자 채용 관리
• 데이터 관리 및 전자 데이터 캡처(EDC) 서비스
• IRB(임상시험 심사 위원회)
• 기타

제5장 임상시험 지원 서비스 시장 분석 : 단계별

• 주요 조사 결과
• 시장 매력 지수
• 시장 규모 추산·예측
• 단계 I
• 단계 II
• 단계 III
• 단계 IV

제6장 임상시험 지원 서비스 시장 분석 : 스폰서별

• 주요 조사 결과
• 시장 매력 지수
• 시장 규모 추산·예측
• 제약회사·바이오의약품 회사
• 의료기기 제조업체
• 기타

제7장 임상시험 지원 서비스 시장 분석 : 지역별

• 주요 조사 결과
• 시장 규모 추산·예측

제8장 북미의 임상시험 지원 서비스 시장 분석

제9장 유럽의 임상시험 지원 서비스 시장 분석

제10장 아시아태평양의 임상시험 지원 서비스 시장 분석

제11장 라틴아메리카의 임상시험 지원 서비스 시장 분석

제12장 중동 및 아프리카의 임상시험 지원 서비스 시장 분석

제13장 기업 개요

• 경쟁 환경
• 전략적 전망
• Thermo Fisher Scientific Inc.
• Eurofins Scientific
• IQVIA Inc.
• WuXi AppTec
• Parexel International Corporation
• Merative
• Calyx
• Caidya
• Laboratory Corporation of America
• ICON plc

제14장 결론·제안

영문목차

The global Clinical Trials Support Services market is projected to grow at a CAGR of 7.7% by 2033.

“The Clinical Trials Support Services Market Report 2023-2033”: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.

Factors such as R&D, Clinical Trials Outsourcing and Globalization Driving Industry Growth

The market for clinical trials support services has witnessed substantial growth in recent times, with several pivotal factors shaping the pharmaceutical and biotechnology research landscape. Among the key drivers is the escalating demand for innovative and specialized treatments, which has led to a significant rise in clinical trial activities. As pharmaceutical companies strive to develop cutting-edge therapies to address unmet medical needs, the need for comprehensive clinical trials support services has surged considerably.

Moreover, the increasing prevalence of chronic illnesses and the aging population have necessitated broader and more diverse clinical trials. Conditions like cancer, cardiovascular disorders, and neurological ailments have seen a marked increase, prompting the requirement for larger and more intricate trials to assess the safety and effectiveness of potential treatments. Consequently, pharmaceutical and biotechnology firms are enlisting the assistance of specialized clinical trial support service providers to navigate the complexities of these trials more effectively.

Additionally, the growing focus on adhering to regulatory standards and ensuring data quality has fuelled the demand for specialized expertise and technological advancements in the clinical trial domain. Regulatory authorities worldwide have tightened their scrutiny of clinical trial data, making it crucial for companies to uphold the highest quality standards. As a result, the adoption of advanced technologies and data management solutions, such as electronic data capture (EDC) and clinical trial management systems (CTMS), has become pivotal to guarantee data accuracy, security, and regulatory compliance.

Collectively, these drivers have played a significant role in propelling the notable growth of the clinical trials support services market. As the healthcare landscape continues to evolve and progress, the demand for specialized and comprehensive clinical trial services is projected to further increase, offering fresh prospects and challenges for companies operating within this sector.

Data Quality and Management Issues such as Errors, Omissions, and Validation Gaps Risk Patient Safety and Trial Efficiency

In recent years, the clinical trials support services market has experienced remarkable growth, driven by a rising demand for outsourced solutions to streamline and expedite drug development processes. Nevertheless, the industry faces several challenges, and a significant impediment relates to the management and quality of data. The accuracy and reliability of data play a crucial role in clinical trials, forming the foundation for well-informed decision-making and ensuring precise outcomes and conclusions.

Various factors contribute to data quality issues, including errors during data collection, incomplete or missing data, inadequate validation processes, and inconsistencies in data entry. These factors can compromise the overall integrity of the trial, leading to erroneous conclusions and, more importantly, potentially jeopardizing the safety of patients. Additionally, poorly managed data can lead to delays in project timelines and escalated costs, negatively impacting the efficiency of the entire trial process.

Moreover, data management concerns encompass the need for data security and the assurance that patient information remains confidential and compliant with privacy regulations. Inadequate data protection measures may expose sensitive information to unauthorized access, leading to breaches and potential legal repercussions.

What Questions Should You Ask before Buying a Market Research Report?

• How is the clinical trials support services market evolving?
• What is driving and restraining the clinical trials support services market?
• How will each clinical trials support services market segment grow over the forecast period and how much revenue will these submarkets account for in 2033?
• How will the market shares for each clinical trials support services market submarket develop from 2023 to 2033?
• What will be the main driver for the overall market from 2023 to 2033?
• Will leading clinical trials support services markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others?
• How will the market shares of the national markets change by 2033 and which geographical region will lead the market in 2033?
• Who are the leading players and what are their prospects over the forecast period?
• How will the industry evolve during the period between 2023 and 2033? What are the implications of clinical trials support services projects taking place now and over the next 10 years?
• Is there a greater need for product commercialisation to further scale the clinical trials support services market?
• Where is the clinical trials support services market heading and how can you ensure you are at the forefront of the market?
• What are the best investment options for new product and service lines?
• What are the key prospects for moving companies into a new growth path and C-suite?

You need to discover how this will impact the clinical trials support services market today, and over the next 10 years:

• Our 262-page report provides 99 tables, 132 charts/graphs exclusively to you
• The report highlights key lucrative areas in the industry so you can target them - NOW
• It contains in-depth analysis of global, regional and national sales and growth
• It highlights for you the key successful trends, changes and revenue projections made by your competitors.

This report tells you TODAY how the clinical trials support services market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.

Forecasts to 2033 and other analyses reveal commercial prospects

• In addition to revenue forecasting to 2033, our new study provides you with recent results, growth rates, and market shares
• You will find original analyses, with business outlooks and developments
• Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising clinical trials support services prices and recent developments.

This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, ""V" ", "L", "W" and "U" are discussed in this report.

By Service

• Clinical trial site management
• Patient recruitment management
• Data Management and Electronic Data Capture (EDC) Services
• IRB (Institutional Review Boards)
• Others

Phase

• Phase I
• Phase II
• Phase III
• Phase IV

Sponsor

• Pharmaceutical & Biopharmaceutical Companies
• Medical Device Manufacturers
• Others

In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for four regional and 20 leading national markets:

North America

• U.S
• Canada

Europe

• Germany
• Spain
• UK
• France
• Italy
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Rest of Asia Pacific

Latin America

• Brazil
• Mexico
• Rest of Latin America

MEA

• GCC Countries
• South Africa
• Rest of MEA

The report also includes profiles and for some of the leading companies in the Clinical Trials Support Services Market, 2023 to 2033, with a focus on this segment of these companies' operations.

Leading companies and the potential for market growth:

Overall world revenue for Clinical Trials Support Services Market, 2023 to 2033 in terms of value the market will surpass US$21 billion in 2023, our work calculates. We predict strong revenue growth through to 2033. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

How will the Clinical Trials Support Services Market, 2023 to 2033 report help you?

In summary, our 260+ page report provides you with the following knowledge:

• Revenue forecasts to 2033 for Clinical Trials Support Services Market 2023 to 2033, with forecasts for service, phase, and sponsor each forecast at a global and regional level - discover the industry's prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2033 for four regional and 20 key national markets - See forecasts for the Clinical Trials Support Services Market, 2023 to 2033 market in North America, Europe, Asia-Pacific, Latin America and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market - including company profiles for 10 of the major companies involved in the Clinical Trials Support Services Market, 2023 to 2033.

Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.

Information found nowhere else

With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Our study is for everybody needing commercial analyses for the Clinical Trials Support Services Market, 2023 to 2033, market-leading companies. You will find data, trends and predictions.

Table of Contents

1 Report Overview

• 1.1 Objectives of the Study
• 1.2 Introduction to Clinical Trials Support Services Market
• 1.3 What This Report Delivers
• 1.4 Why You Should Read This Report
• 1.5 Key Questions Answered by This Analytical Report
• 1.6 Who is This Report for?
• 1.7 Methodology
  • 1.7.1 Market Definitions
  • 1.7.2 Market Evaluation & Forecasting Methodology
  • 1.7.3 Data Validation
    • 1.7.3.1 Primary Research
    • 1.7.3.2 Secondary Research
• 1.8 Frequently Asked Questions (FAQs)
• 1.9 Associated Visiongain Reports
• 1.10 About Visiongain

2 Executive Summary

3 Market Overview

• 3.1 Key Findings
• 3.2 Market Dynamics
  • 3.2.1 Market Driving Factors
    • 3.2.1.1 Increasing R&D Activities and Increasing Clinical Trials Activities
    • 3.2.1.2 Outsourcing of Clinical Trials Activities Driving Industry Growth
    • 3.2.1.3 Globalization of Clinical Trials Projected to Boost Industry Growth
  • 3.2.2 Market Restraining Factors
    • 3.2.2.1 Strict Regulatory and High Compliance Complexity Likely to Hamper Industry Growth
    • 3.2.2.2 Data Quality and Management Issues Reducing Reliability of Data
    • 3.2.2.3 Patient Recruitment and Retention Over a Diverse Patient Population
  • 3.2.3 Market Opportunities
    • 3.2.3.1 Patient-centric Approaches and Technological Advancements Projected to Offer Lucrative Growth Prospects
    • 3.2.3.2 Precision Medicine and Biomarker-driven Trials
    • 3.2.3.3 Virtual and Decentralized Trials Offering Remote Monitoring, Telemedicine Solutions, and Digital Patient Engagement Platforms
• 3.3 COVID-19 Impact Analysis
• 3.4 Porter's Five Forces Analysis
  • 3.4.1 Bargaining Power of Suppliers
  • 3.4.2 Bargaining Power of Buyers
  • 3.4.3 Competitive Rivalry
  • 3.4.4 Threat from Substitutes
  • 3.4.5 Threat of New Entrants
• 3.5 PEST Analysis
  • 3.5.1 Political
  • 3.5.2 Economical
  • 3.5.3 Social
  • 3.5.4 Technological

4 Clinical Trials Support Services Market Analysis by Service

• 4.1 Key Findings
• 4.2 Service Segment: Market Attractiveness Index
• 4.3 Clinical Trials Support Services Market Size Estimation and Forecast by Service
• 4.4 Clinical Trial Site Management
  • 4.4.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.4.2 Market Share by Region, 2023 & 2033 (%)
• 4.5 Patient Recruitment Management
  • 4.5.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.5.2 Market Share by Region, 2023 & 2033 (%)
  • 4.5.3 Patient Recruitment Management in Clinical Trials Support Services Market
• 4.6 Data Management and Electronic Data Capture (EDC) Services
  • 4.6.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.6.2 Market Share by Region, 2023 & 2033 (%)
• 4.7 IRB (Institutional Review Boards)
  • 4.7.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.7.2 Market Share by Region, 2023 & 2033 (%)
• 4.8 Others
  • 4.8.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 4.8.2 Market Share by Region, 2023 & 2033 (%)

5 Clinical Trials Support Services Market Analysis by Phase

• 5.1 Key Findings
• 5.2 Phase Segment: Market Attractiveness Index
• 5.3 Clinical Trials Support Services Market Size Estimation and Forecast by Phase
• 5.4 Phase I
  • 5.4.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 5.4.2 Market Share by Region, 2023 & 2033 (%)
• 5.5 Phase II
  • 5.5.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 5.5.2 Market Share by Region, 2023 & 2033 (%)
• 5.6 Phase III
  • 5.6.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 5.6.2 Market Share by Region, 2023 & 2033 (%)
• 5.7 Phase IV
  • 5.7.2 Market Size by Region, 2023-2033 (US$ Billion)
  • 5.7.3 Market Share by Region, 2023 & 2033 (%)

6 Clinical Trials Support Services Market Analysis by Sponsor

• 6.1 Key Findings
• 6.2 Sponsor Segment: Market Attractiveness Index
• 6.3 Clinical Trials Support Services Market Size Estimation and Forecast by Sponsor
• 6.4 Pharmaceutical & Biopharmaceutical Companies
  • 6.4.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 6.4.2 Market Share by Region, 2023 & 2033 (%)
• 6.5 Medical Device Manufacturers
  • 6.5.2 Market Size by Region, 2023-2033 (US$ Billion)
  • 6.5.3 Market Share by Region, 2023 & 2033 (%)
• 6.6 Others
  • 6.6.1 Market Size by Region, 2023-2033 (US$ Billion)
  • 6.6.2 Market Share by Region, 2023 & 2033 (%)

7 Clinical Trials Support Services Market Analysis by Region

• 7.1 Key Findings
• 7.3 Regional Market Size Estimation and Forecast

8 North America Clinical Trials Support Services Market Analysis

• 8.1 Key Findings
• 8.2 North America Clinical Trials Support Services Market Attractiveness Index
• 8.3 North America Clinical Trials Support Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 8.4 North America Clinical Trials Support Services Market Size Estimation and Forecast by Country
• 8.5 North America Clinical Trials Support Services Market Size Estimation and Forecast by Service
  • 8.5.1 North America Patient Recruitment Management in Clinical Trials Support Services Market Size Estimation and Forecast by Services
• 8.6 North America Clinical Trials Support Services Market Size Estimation and Forecast by Phase
• 8.7 North America Clinical Trials Support Services Market Size Estimation and Forecast by Sponsor
• 8.8 U.S. Clinical Trials Support Services Market Analysis
• 8.9 Canada Clinical Trials Support Services Market Analysis

9 Europe Clinical Trials Support Services Market Analysis

• 9.1 Key Findings
• 9.2 Europe Clinical Trials Support Services Market Attractiveness Index
• 9.3 Europe Clinical Trials Support Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 9.4 Europe Clinical Trials Support Services Market Size Estimation and Forecast by Country
• 9.5 Europe Clinical Trials Support Services Market Size Estimation and Forecast by Service
  • 9.5.1 Europe Patient Recruitment Management in Clinical Trials Support Services Market Size Estimation and Forecast by Services
• 9.6 Europe Clinical Trials Support Services Market Size Estimation and Forecast by Phase
• 9.7 Europe Clinical Trials Support Services Market Size Estimation and Forecast by Sponsor
• 9.8 Germany Clinical Trials Support Services Market Analysis
• 9.9 France Clinical Trials Support Services Market Analysis
• 9.10 UK Clinical Trials Support Services Market Analysis
• 9.11 Italy Clinical Trials Support Services Market Analysis
• 9.12 Spain Clinical Trials Support Services Market Analysis
• 9.13 Rest of Europe Clinical Trials Support Services Market Analysis

10 Asia Pacific Clinical Trials Support Services Market Analysis

• 10.1 Key Findings
• 10.2 Asia Pacific Clinical Trials Support Services Market Attractiveness Index
• 10.3 Asia Pacific Clinical Trials Support Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 10.4 Asia Pacific Clinical Trials Support Services Market Size Estimation and Forecast by Country
• 10.5 Asia Pacific Clinical Trials Support Services Market Size Estimation and Forecast by Service
  • 10.5.1 Asia Pacific Patient Recruitment Management in Clinical Trials Support Services Market Size Estimation and Forecast by Services
• 10.6 Asia Pacific Clinical Trials Support Services Market Size Estimation and Forecast by Phase
• 10.7 Asia Pacific Clinical Trials Support Services Market Size Estimation and Forecast by Sponsor
• 10.8 China Clinical Trials Support Services Market Analysis
• 10.9 Japan Clinical Trials Support Services Market Analysis
• 10.10 India Clinical Trials Support Services Market Analysis
• 10.11 Australia Clinical Trials Support Services Market Analysis
• 10.12 South Korea Clinical Trials Support Services Market Analysis
• 10.13 Rest of Asia Pacific Clinical Trials Support Services Market Analysis

11 Latin America Clinical Trials Support Services Market Analysis

• 11.1 Key Findings
• 11.2 Latin America Clinical Trials Support Services Market Attractiveness Index
• 11.3 Latin America Clinical Trials Support Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 11.4 Latin America Clinical Trials Support Services Market Size Estimation and Forecast by Country
• 11.5 Latin America Clinical Trials Support Services Market Size Estimation and Forecast by Service
  • 11.5.1 Latin America Patient Recruitment Management in Clinical Trials Support Services Market Size Estimation and Forecast by Services
• 11.6 Latin America Clinical Trials Support Services Market Size Estimation and Forecast by Phase
• 11.7 Latin America Clinical Trials Support Services Market Size Estimation and Forecast by Sponsor
• 11.8 Brazil Clinical Trials Support Services Market Analysis
• 11.9 Mexico Clinical Trials Support Services Market Analysis
• 11.10 Rest of Latin America Clinical Trials Support Services Market Analysis

12 MEA Clinical Trials Support Services Market Analysis

• 12.1 Key Findings
• 12.2 MEA Clinical Trials Support Services Market Attractiveness Index
• 12.3 MEA Clinical Trials Support Services Market by Country, 2023, 2028 & 2033 (US$ Billion)
• 12.4 MEA Clinical Trials Support Services Market Size Estimation and Forecast by Country
• 12.5 MEA Clinical Trials Support Services Market Size Estimation and Forecast by Service
  • 12.5.1 MEA Patient Recruitment Management in Clinical Trials Support Services Market Size Estimation and Forecast by Services
• 12.6 MEA Clinical Trials Support Services Market Size Estimation and Forecast by Phase
• 12.7 MEA Clinical Trials Support Services Market Size Estimation and Forecast by Sponsor
• 12.8 GCC Clinical Trials Support Services Market Analysis
• 12.9 South Africa Clinical Trials Support Services Market Analysis
• 12.10 Rest of MEA Clinical Trials Support Services Market Analysis

13 Company Profiles

• 13.1 Competitive Landscape, 2022
• 13.2 Strategic Outlook
• 13.3 Thermo Fisher Scientific Inc.
  • 13.3.1 Company Snapshot
  • 13.3.2 Company Overview
  • 13.3.3 Financial Analysis
    • 13.3.3.1 Net Revenue, 2018-2022
    • 13.3.3.2 Regional Market Shares, 2022
  • 13.3.4 Services Offered
  • 13.3.5 Strategic Outlook
• 13.4 Eurofins Scientific
  • 13.4.1 Company Snapshot
  • 13.4.2 Company Overview
  • 13.4.3 Financial Analysis
    • 13.4.3.1 Net Revenue, 2018-2022
    • 13.4.3.2 Regional Market Shares, 2022
  • 13.4.4 Services Offered
  • 13.4.5 Strategic Outlook
• 13.5 IQVIA Inc.
  • 13.5.1 Company Snapshot
  • 13.5.2 Company Overview
  • 13.5.3 Financial Analysis
    • 13.5.3.1 Revenue, 2018-2022
    • 13.5.3.2 Regional Market Shares, 2022
    • 13.5.3.3 R&D Expense, 2018-2022
  • 13.5.4 Services Offered
  • 13.5.5 Strategic Outlook
• 13.6 WuXi AppTec
  • 13.6.1 Company Snapshot
  • 13.6.2 Company Overview
  • 13.6.3 Financial Analysis
    • 13.6.3.1 Revenue, 2019-2022
    • 13.6.3.2 Regional Market Shares, 2022
  • 13.6.4 Services Offered
  • 13.6.5 Strategic Outlook
• 13.7 Parexel International Corporation
  • 13.7.1 Company Snapshot
  • 13.7.2 Company Overview
  • 13.7.3 Services Offered
  • 13.7.4 Strategic Outlook
• 13.8 Merative
  • 13.8.1 Company Snapshot
  • 13.8.2 Company Overview
  • 13.8.3 Services Offered
  • 13.8.4 Strategic Outlook
• 13.9 Calyx
  • 13.9.1 Company Snapshot
  • 13.9.2 Company Overview
  • 13.9.3 Services Offered
  • 13.9.4 Strategic Outlook
• 13.10 Caidya
  • 13.10.1 Company Snapshot
  • 13.10.2 Company Overview
  • 13.10.3 Services Offered
  • 13.10.4 Strategic Outlook
• 13.11 Laboratory Corporation of America
  • 13.11.1 Company Snapshot
  • 13.11.2 Company Overview
  • 13.11.3 Financial Analysis
    • 13.11.3.1 Revenue, 2018-2022
    • 13.11.3.2 Regional Market Shares, 2022
  • 13.11.4 Services Offered
  • 13.11.5 Strategic Outlook
• 13.12 ICON plc
  • 13.12.1 Company Snapshot
  • 13.12.2 Company Overview
  • 13.12.3 Financial Analysis
    • 13.12.3.1 Revenue, 2018-2022
    • 13.12.3.2 Regional Market Shares, 2022
  • 13.12.4 Services Offered
  • 13.12.5 Strategic Outlook

14 Conclusion and Recommendations

• 14.1 Concluding Remarks from Visiongain
• 14.2 Recommendations for Market Players